Cargando…
Fixed Dose Combination of Arterolane and Piperaquine: A Newer Prospect in Antimalarial Therapy
Malaria has been very prevalent vector-borne disease in India and until date bears enormous implications on health care services of the country. Over the period of time, the development of resistance to traditional antimalarials like chloroquine has been posed as major deterrent in efforts of malari...
Autores principales: | Patil, CY, Katare, SS, Baig, MS, Doifode, SM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160665/ https://www.ncbi.nlm.nih.gov/pubmed/25221689 http://dx.doi.org/10.4103/2141-9248.139270 |
Ejemplares similares
-
Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
por: Hamaluba, Mainga, et al.
Publicado: (2021) -
Enantioselective
Synthesis and in Vivo Evaluation
of Regioisomeric Analogues of the Antimalarial Arterolane
por: Blank, Brian R., et al.
Publicado: (2017) -
Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study
por: Valecha, Neena, et al.
Publicado: (2016) -
Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study
por: Toure, Offianan Andre, et al.
Publicado: (2015) -
Monoclonal Antibodies That Recognize the Alkylation
Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
por: Jourdan, Joëlle, et al.
Publicado: (2015)